# Spero Therapeutics, Inc.: Form 8-K, filed Jan 30, 2026

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: 8-K
- Filed: 2026-01-30
- Accepted by EDGAR: Jan 30, 2026, 17:01 ET
- Period: 2026-01-30
- Accession: 0001193125-26-032004
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312526032004/d55903d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312526032004/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312526032004/d55903d8k.htm

Filed Jan 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-032004. Last ingested by Listed: Oct 29, 2026, 04:34 ET. No prices; not investment advice.